Give And Take As China Finalizes Biosimilars Guideline
This article was originally published in PharmAsia News
Three months after publishing a draft guideline on biosimilars, China's Food and Drug Administration (CFDA) has just released the final official version, although it is still dubbed a pilot scheme. The new guideline may superficially look similar to the draft, but a closer comparison reveals some key differences.
You may also be interested in...
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
The German pricing and reimbursement system has been successful in recognizing the value and uniqueness of orphan drugs.
Erectile problems prevent a quarter of Brits from being intimate with a partner. Viatris' Upjohn - which markets Viagra Connect in the UK - is working with the Men’s Health Forum, sexual health charity Brook and dating expert Sarah Louise Ryan raise awareness of the problem and get men talking about the issue with their partners and with healthcare professionals.